Gaingels

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.

Marc Baum

Investor

David Beatty

Managing Partner

Jesse Curran

Principal

Nancy Fechnay

Venture Partner

Paul Grossinger

Investor

Past deals in Health Diagnostics

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.

Testmate Health

Seed Round in 2024
Testmate Health is a medtech startup and award-winning spin-off of the University of Geneva in Switzerland. It has developed a smartphone-compatible platform test kit capable of diagnosing diseases based on identifiable DNA or RNA sequences without the need for a laboratory, delivering results in minutes at home. The initial product is a rapid urine self-test for the four most common sexually transmitted infections, designed to be used outside clinical settings and to provide a smartphone-scanable result that supports immediate access to treatment if needed. The platform uses DNA isothermal technology to detect infectious diseases with identifiable DNA, enabling home testing without laboratory submission. Further test kits for additional diseases are in development to empower users to monitor their health from home.

Limbic

Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Ezra AI

Series B in 2024
Ezra AI, Inc. is a company focused on developing artificial intelligence technology to enhance cancer detection through investigational devices. Established in 2017 and headquartered in New York, it has pioneered a novel approach to cancer screening utilizing full-body MRI technology supported by AI. The company's initial product is an FDA-cleared software designed to assist radiologists in interpreting MRI images specifically for prostate cancer. Ezra AI primarily serves customers in New York and California, aiming to improve early cancer detection and diagnosis through its innovative solutions.

Parsley Health

Venture Round in 2024
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.

Resistomap

Seed Round in 2023
Resistomap is a company that specializes in monitoring antibiotic resistance through data-driven laboratory services. It focuses on mitigating the spread of antibiotic resistance in the environment by offering robust monitoring tools. The company integrates expertise in molecular genetics and data science with high-throughput real-time polymerase chain reaction technology. This combination allows Resistomap to deliver comprehensive laboratory and analysis services that facilitate environmental monitoring of antibiotic resistance, aiding customers in understanding and addressing this critical public health issue.

Allara Health

Series A in 2023
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Carenostics

Seed Round in 2023
Carenostics is a health technology company that uses artificial intelligence and machine learning to address underdiagnosis, undertreatment, and health inequities in chronic disease care. Its detection models analyze data from routine patient care and integrate with provider electronic health records to identify undiagnosed chronic conditions, project disease progression, and help clinicians prioritize patients for timely intervention.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Sequencing.com

Seed Round in 2022
Sequencing.com is an innovative platform that serves as the first open operating system for DNA sequencing, storage, and analysis. It provides consumers, bioinformatics developers, pharmaceutical companies, and health and wellness providers with tools to analyze genetic data from various third-party genetic tests, including those from 23andMe and Ancestry.com. The platform supports the development and marketing of over 100 DNA analysis applications, which deliver insights on personalized medicine, preventive health, and genealogy, among other areas. By allowing users to upload their DNA data, Sequencing.com offers comprehensive reports that assist in health optimization, screening for rare diseases, and assessing medication reactions. Additionally, its DNA-as-a-service model enables healthcare and wellness organizations to customize their genetic testing and analysis pipelines for a variety of purposes, facilitating better health outcomes and personalized wellness solutions.

Gabbi

Seed Round in 2022
Gabbi is a healthcare technology company that uses AI and clinical research to help women understand and proactively manage their health risks, with a focus on breast cancer risk, prevention, and early detection. The platform offers a lifetime risk assessment, personalized action plans, and virtual care options such as video appointments and chat, along with a community network that supports ongoing engagement and informed decision making.

Disclo

Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.

Choiz

Seed Round in 2022
Choiz is a healthcare platform that provides a personalized, end-to-end care experience delivered directly to patients at home. It covers diagnosis, prescription and delivery of medications, and ongoing remote care managed by health professionals. The platform aims to expand access to specialized treatments, including programs for hair growth, skincare, and weight loss, with regular medication supplies and continuous support without requiring in-person visits.

Magnetic Insight

Series B in 2022
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

Swing Therapeutics

Series A in 2022
Swing develops safe and effective digital therapeutics for chronic conditions, partnering with top researchers to create evidence-based treatments. Their solutions empower patients to manage their illnesses, improving health outcomes.

Starling Medical

Seed Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

Ray studios

Pre Seed Round in 2022
Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

Wavely Diagnostics

Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Sonic Incytes Medical Corp

Series A in 2021
Sonic Incytes Medical Corp develops handheld ultrasound solutions for point-of-care assessment and monitoring of chronic liver diseases. It uses quantitative ultrasound and elastography with artificial intelligence to provide deeper measurements, larger tissue samples, and single-probe operation without recalibrations, enabling guidance for diagnostics and procedures. The devices assess liver stiffness, attenuation, and fat fraction to support diagnosis and management of liver health. The company was incorporated in 2012 and is based in Vancouver, Canada.

OxiWear

Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices specifically designed for continuous oxygen monitoring and emergency alerting, targeting patients prone to silent hypoxia due to conditions such as pulmonary hypertension, high-altitude environments, high-intensity cardio activities, and COVID-19. The company's patented pulse oximeter offers a novel approach to monitoring oxygen levels, facilitating use in both clinical and consumer settings. By providing real-time data and alerts, OxiWear's technology enhances patient safety and peace of mind, ensuring timely medical assistance when needed.

Zeit Medical

Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

Sonavi Labs

Seed Round in 2021
Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

EIO Diagnostics

Seed Round in 2021
EIO Diagnostics Inc. is a Canadian company specializing in udder health technology for dairy farming. Founded in 2017 and based in Duncan, it develops the FirstLook Mastitis detection system, which aims to prevent mastitis infections in dairy animals. The system employs a multispectral sensor installed at the entrance of the milk parlor to capture images of the udder as cows enter, enabling early detection of infection indicators through advanced infrared image analysis and computer vision. This technology automates the screening process, allowing farmers to monitor udder health efficiently, reduce labor costs, and enhance milk quality.

Crescent Health

Pre Seed Round in 2021
Crescent Health is working to make sleep health accessible to all. It hastens the development of individual health, beginning with sleep. They are employed by meet sleep coach. Connecting a sleep monitor to an app get monthly customized sleep plans, track sleep health, and find the ideal schedule.

ConnectCareHero

Pre Seed Round in 2021
ConnectCareHero operates a digital platform that curates local entertainment options and facilitates social engagement for older adults. This helps healthcare organizations enhance activity programming, reduce senior isolation, and improve overall health outcomes.

Brave Care

Series A in 2021
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.

FULLFILL

Seed Round in 2021
FULLFILL is a digital platform offering virtual health coaching programs designed to prevent and treat chronic conditions. It partners with employers worldwide to improve employee health and reduce medical expenses. The platform offers evidence-based content, daily support from Master Coaches, and engages employees effectively, doubling medical results compared to traditional programs.

norahealth.ai

Pre Seed Round in 2021
In the next decade, expect a revolutionary redesign of healthcare for instant guidance. Starting from joint & muscle care, Nora is the first AI knowledge assistant that delivers precise and medically sound guidance right when you need it. Leveraging a seamless fusion of conversational AI and proprietary computer vision models to automatize patient intake and physical examination, we unlock immediate guidance and care access for acute pain in less than 10 minutes.

Cerebral

Series A in 2020
Cerebral Inc. is a mental health telemedicine company that offers an online membership platform designed to provide accessible and affordable mental health care. Founded in 2019 and headquartered in Walnut, California, Cerebral specializes in addressing conditions such as anxiety, depression, and insomnia. The platform enables users to engage in medication management, counseling, and therapy, while also facilitating regular assessments and video appointments with care counselors. Additionally, it provides ongoing check-ins and messaging support from assigned care managers, along with prescription services and medication delivery. By employing evidence-based guidelines, Cerebral aims to improve the overall mental-emotional health of its patients, making high-quality care more accessible to a broader audience.

Phosphorus

Venture Round in 2020
Phosphorus, Inc. is a clinical genetic testing company that specializes in diagnostic kits designed to identify inherited risks for various diseases, including cancer, heart disease, and vision loss. Among its offerings are PhosphorusONE, HeartMap, and LipidMap, which focus on a range of hereditary conditions such as sudden cardiac death and high cholesterol. The company provides extensive panel-based genetic testing in areas including fertility, cardiology, oncology, and more. Phosphorus also offers a COVID-19 saliva test and Element, a software solution for managing genetic tests and clinical data. With a CLIA and CAP certified laboratory, Phosphorus ensures its tests meet high standards and are available to individuals through healthcare providers, hospitals, and directly via its online platform. Established in 2016 and headquartered in New York, with a laboratory in Secaucus, New Jersey, Phosphorus aims to make genetics integration in medicine cost-effective and accessible.

Leda Health

Pre Seed Round in 2020
Leda Health is a healthcare services company focused on transforming systems related to sexual assault prevention, care, and justice to better support survivors and their communities. The company is developing a holistic care program that includes innovative solutions for forensic evidence collection and testing. Utilizing modern technology, Leda Health offers a mobile application that guides users through the evidence collection process, along with early evidence kits and access to a dedicated care team. Additionally, Leda Health provides healing circles, creating a comprehensive support system aimed at enhancing the overall experience for survivors. Through these services, the company seeks to facilitate a more accessible and user-friendly approach to care in sensitive situations.

Sonavi Labs

Venture Round in 2020
Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Nines

Series A in 2019
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Parsley Health

Series B in 2019
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.

Ophidion

Venture Round in 2019
Ophidion is a biotechnology company focused on developing therapeutics for central nervous system disorders, particularly neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. Utilizing a Trojan horse strategy, the company exploits an endogenous receptor-mediated transport system to deliver small molecule drugs and biologics directly into the brain. Ophidion specializes in gene-silencing therapies, including oligonucleotides and small interfering ribonucleic acids (siRNAs), which can be administered intravenously. In addition to its core focus on neurodegenerative diseases, Ophidion is advancing an innovative program aimed at treating anxiety-related disorders, which includes a patented companion biomarker diagnostic to optimize patient selection for treatment. The company's platform technology is versatile, capable of delivering various classes of drugs, including macromolecules like gene therapeutics, antibodies, and peptides, positioning Ophidion at the forefront of therapeutic advancements in CNS treatment.

Sepsis Scout

Seed Round in 2019
Sepsis Scout is a developer of a wearable patch designed to predict the onset of sepsis in high-risk patients in home care settings. Utilizing proprietary deep learning technology, the device aims to detect sepsis more accurately than current standards of care. By enabling patients to manage chronic illnesses effectively, Sepsis Scout's solution helps individuals stay out of the hospital and alleviates the fear and uncertainty associated with serious health conditions. The company's focus on artificial intelligence and wearables positions it at the forefront of innovative healthcare solutions.

Ro

Series B in 2019
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Kenzen

Convertible Note in 2018
Kenzen, Inc. is a health technology company that specializes in developing wearable solutions for health and performance monitoring. Its flagship product, the Kenzen ECHO, is a wireless smart patch designed to provide real-time monitoring of vital signs and physiological data, with a focus on preventing injuries related to heat stress, fatigue, and over-exertion in industrial settings. The ECHO system includes a mobile application that delivers personalized health insights and alerts, ensuring that workers and their supervisors can take proactive measures to enhance safety and productivity. Incorporated in 2014 and based in New York, Kenzen sells its products through various distributors, resellers, and retail locations, aiming to harness physiological data to improve workforce safety and well-being.

Sonavex

Series A in 2018
Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.

Vixiar

Venture Round in 2018
Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.

Kenzen

Seed Round in 2017
Kenzen, Inc. is a health technology company that specializes in developing wearable solutions for health and performance monitoring. Its flagship product, the Kenzen ECHO, is a wireless smart patch designed to provide real-time monitoring of vital signs and physiological data, with a focus on preventing injuries related to heat stress, fatigue, and over-exertion in industrial settings. The ECHO system includes a mobile application that delivers personalized health insights and alerts, ensuring that workers and their supervisors can take proactive measures to enhance safety and productivity. Incorporated in 2014 and based in New York, Kenzen sells its products through various distributors, resellers, and retail locations, aiming to harness physiological data to improve workforce safety and well-being.

Kenzen

Seed Round in 2016
Kenzen, Inc. is a health technology company that specializes in developing wearable solutions for health and performance monitoring. Its flagship product, the Kenzen ECHO, is a wireless smart patch designed to provide real-time monitoring of vital signs and physiological data, with a focus on preventing injuries related to heat stress, fatigue, and over-exertion in industrial settings. The ECHO system includes a mobile application that delivers personalized health insights and alerts, ensuring that workers and their supervisors can take proactive measures to enhance safety and productivity. Incorporated in 2014 and based in New York, Kenzen sells its products through various distributors, resellers, and retail locations, aiming to harness physiological data to improve workforce safety and well-being.

Collective Health

Series A in 2014
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Biostate AI

Biostate AI specializes in developing a comprehensive biotechnology data aggregation and analysis platform. This platform integrates diverse data sources such as clinical trial results, regulatory information, and scientific publications, providing tools for data visualization, trend analysis, and predictive insights. The company's solution enables researchers to assess drug development progress and make evidence-based decisions, ultimately benefiting human health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.